61674-96-2

Basic information

• Product Name: 2-Butanone, 3,3-dimethyl-4-(phenylmethoxy)-
• Synonyms: 4-benzyloxy-3,3-dimethyl-butan-2-one
• CAS NO: 61674-96-2
• Molecular Formula: C13H18O2
• Molecular Weight: 206.285
• Mol File: 61674-96-2.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 2-Butanone, 3,3-dimethyl-4-(phenylmethoxy)-(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Butanone, 3,3-dimethyl-4-(phenylmethoxy)-(61674-96-2)
• EPA Substance Registry System: 2-Butanone, 3,3-dimethyl-4-(phenylmethoxy)-(61674-96-2)

Safety Data

• Hazardous Substances Data: 61674-96-2(Hazardous Substances Data)

Upstream product

• 1823-90-1 4-hydroxy-3,3-dimethyl-butan-2-one 
• 100-39-0 benzyl bromide 
• 563-80-4 3-methyl-butan-2-one 
• 3587-60-8 Benzyloxymethyl chloride 
• 3814-41-3 3-methylbut-2-en-2-yl acetate 

Downstream Products

• 749260-95-5 C₂₅H₄₀O₄Si 
• 566927-61-5 (7R,9S,10S)-1-Benzyloxy-9-methoxy-10-methoxymethoxy-2,2-dimethyl-7-triethylsilanyloxy-dodec-11-ene-3,5-dione 
• 749260-65-9 C₃₀H₅₀O₇Si 
• 24706-89-6 2,2-dimethyl-1-tosyloxy-butan-3-one 
• 566927-66-0 (2R,3S)-4-[(2R,4S,5S,6S)-6-(2-Benzyloxy-1,1-dimethyl-ethyl)-4,6-dimethoxy-5-triethylsilanyloxy-tetrahydro-pyran-2-yl]-3-methoxy-2-methoxymethoxy-butyric acid methyl ester 
• 566927-65-9 [(2S,3S,4S,6R)-2-(2-Benzyloxy-1,1-dimethyl-ethyl)-2,4-dimethoxy-6-((2S,3S)-2-methoxy-3-methoxymethoxy-pent-4-enyl)-tetrahydro-pyran-3-yloxy]-triethyl-silane 
• 566927-64-8 (2S,3S,4S,6S)-2-(2-Benzyloxy-1,1-dimethyl-ethyl)-2-methoxy-6-((2S,3S)-2-methoxy-3-methoxymethoxy-pent-4-enyl)-tetrahydro-pyran-3,4-diol 
• 749260-72-8 (2S,3S,4S,6S)-2-(2-Benzyloxy-1,1-dimethyl-ethyl)-2,4-dimethoxy-6-((2S,3S)-2-methoxy-3-methoxymethoxy-pent-4-enyl)-tetrahydro-pyran-3-ol 

Relevant articles and documents

Polycyclic compound and application thereof as antiviral drug

The invention relates to a polycyclic compound and application of the polycyclic compound as an antiviral drug, in particular to a compound shown in a formula (I) or pharmaceutically acceptable salts,solvates, geometric isomers, stereoisomers, tautomers and any mixtures thereof. The compound shown in the formula (I) or the pharmaceutically acceptable salts, solvates and medicinal compositions thereof can be used for treating and/or preventing hepatitis B virus infection, and particularly, the compound, a TLR7 inhibitor and nucleoside medicines can be used as medicinal compositions for curinghepatitis B.

COMBINATION THERAPY OF AN HBSAG INHIBITOR AND AN INTERFERON

The present invention is directed to compositions and methods for treating hepatitis B virus infection. In particular, the present invention is directed to a combination therapy comprising administration of an HBsAg inhibitor and an interferon for use in the treatment or prophylaxis of chronic Hepatitis B virus infections.

NOVEL 6,7-DIHYDROBENZO[A]QUINOLIZIN-2-ONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

The invention provides novel compounds having the general formula (I) wherein R1 to R6, W and X are as described herein and their pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.